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Labeling of native proteins invites interest from diverse segments of science. However, there
remains the significant unmet challenge in precise labeling at a single site of a protein. Here,
we report the site-specific labeling of natural or easy-to-engineer N-terminus Gly in proteins
with remarkable efficiency and selectivity. The method generates a latent nucleophile from
N-terminus imine that reacts with an aldehyde to deliver an aminoalcohol under physiological
conditions. It differentiates N-Gly as a unique target amongst other proteinogenic amino
acids. The method allows single-site labeling of proteins in isolated form and extends to lysed
cells. It administers an orthogonal aldehyde group primed for late-stage tagging with an
affinity tag, 19F NMR probe, and a fluorophore. A user-friendly protocol delivers analytically
pure tagged proteins. The mild reaction conditions do not alter the structure and function of
the protein. The cellular uptake of fluorophore-tagged insulin and its ability to activate the
insulin-receptor mediated signaling remains unperturbed.
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S ingle-site labeling of proteins facilitates investigation of sev-eral biological processes through attachment of biophysicalprobes, imaging probes, and toxins. Such labeling emerges
through pre-engineered protein equipped with unnatural amino
acids1, an amino acid sequence recognized by enzymes2, and single
cysteine3,4 or a cysteine placed in a π-clamp5. The understanding
of organic chemistry with proteins has nurtured the growth of
bioconjugation. These biomolecules can be perceived as a macro-
molecular substrate with multiple nucleophilic functional groups
(NuP). The obvious route for bioconjugation would involve its
reaction with an electrophile (Fig. 1a). For single-site labeling in
such cases, a functional group has to compete with all the other
nucleophilic residues (chemoselectivity) and its additional copies
(site-selectivity). The chemoselective labeling of low-frequency
residues (Cys6,7, Tyr8, and Trp9) can address the latter to some
extent. For other cases, the single-site labeling of side chain func-
tionalities could be driven through ligand–protein interaction10,
linchpin directed modification11 or targeting the ε-amine of most
reactive Lys residue (Nε-NH2)12–16. Alongside, the N-terminus
α-amine (Nα-NH2) has established its place as a notable reactivity
hotspot. In a remarkable example, the biomimetic transformation
of N-terminus residue delivers a carbonyl group primed for sub-
sequent orthogonal reactions17.
The kinetic labeling of Nα-NH2 can be achieved through its
chemoselective modification with an electrophile as determined
by a few groups including us (Fig. 1a)18–30. The alternate route
involves a latent electrophile (EL) generated in the form of imine
from Nα-NH2 and aldehyde (Fig. 1b). It gives us the opportunity
to address the two challenges in two separate steps. If we can
generate EL chemoselectively, the nucleophile is only required to
address the site-selectivity. This approach delivers reductive
alkylation in a chemoselective transformation (path a, Fig. 1b)31.
However, the site-selectivity gets compromised very early in the
reaction in the presence of competing imines. On the contrary,
the nucleophilic attack of backbone amide to imine generated by
Nα-NH2 and 2-pyridinecarboxaldehyde can render isolable imi-
dazolidinone with high selectivity (path b, Fig. 1b)32. Unfortu-
nately, none of these methodologies can distinguish one N-
terminus residue from the other. In this perspective, N-terminal
Cys containing proteins can render unique reactivity to form
thiazolidine with an aldehyde or 2-cyanobenzothiazole (path c,
Fig. 1b)33–35. However, it is a challenge to identify unique reac-
tivity for other N-terminus residues. In particular, selective
targeting of N-terminus Gly poses a prominent complexity as
there is no side-chain residue to assist.
Here, we demonstrate that an aldehyde with appropriately
designed hydrogen bond acceptor can result in the exclusive
labeling of N-terminus Gly residue. The remarkable selectivity of
C–C bond formation extends from an amino acid to structurally
diverse proteins. Besides, the protocol operates conveniently in a
mixture of proteins or cell lysate. The residue-specific installation
of an orthogonal aldehyde group renders analytically pure tagged
proteins in high yields through the late-stage single-site intro-
duction of the desired probe.
Results
We hypothesized that a multi-step transformation could provide
a roadmap to address the challenge of chemoselectivity and
residue selectivity. The initial generation of the EL with capability
to generate another reactive center (latent nucleophile, NuL, path
d) could provide the platform. While the first step can address
chemoselectivity, the latter can give us an opportunity to explore
the residue specificity. Also, the NuL generated with a protein will
be required to display orthogonal reactivity in the presence of
proteinogenic nucleophiles (Fig. 1c). At first, the challenge was to
design an imine that can generate the NuL under physiological
conditions. We hypothesized that H-bond acceptors in the imine
group (Fig. 1b) could assist proton shuttling and stabilize the NuL.
We anticipated that the intramolecular H-bond acceptors might
overcome the competing intermolecular interactions with protein
and solvent. Subsequently, we can explore the reactivity of NuL
towards an external electrophile (Fig. 1c). Also, we anticipated
that the unsubstituted amino acid (Gly) could potentially render
a reactivity profile different from all the other substituted
amino acids.
Aminoalcohol formation with Gly under ambient conditions.
We selected ortho-substituted benzaldehyde to garner the
advantage of geometrical constraint imposed by the aromatic
ring. We placed one H-bond acceptor ortho to the aldehyde in the
form of a methoxy group (2a, Fig. 2a). The reaction of Gly amide
1a with reagent 2a fails to result in any adduct (Fig. 2a). Next, we
designed the reagent 2b that proffers a carbonyl group as H-bond
acceptor. It was exciting to note the formation of isolable product
(3ab, 27% conversion, LC-MS). Encouraged by this result, we
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Fig. 1 Residue-specificity in labeling of proteins. a Nucleophilic addition of protein residues to an electrophile. b A latent electrophile, imine, renders the
N-terminus labeling of proteins (path a–path c). c Latent nucleophile enables single-site N-terminus Gly labeling
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investigated the effect of two oxygen centers as H-bond acceptors
in the reagent 2c. We found it to be inefficient in improving the
conversion to the product (3ac, 33%, LC-MS). The redesigned
reagent 2d led to 63% conversion of the product that further
enhanced (3a, > 95%, LC-MS) with reagent 2e. A non-polar
derivative of product (3a) was purified and characterized as
aminoalcohol after thorough mass and NMR analysis (Supple-
mentary Figs. 13–27).
Unsubstituted amino acid versus substituted amino acids. In
another exciting result, we noted that the imine formed by Ala 1b
remained inert towards any subsequent transformation contrary
to Gly 1a (Fig. 2b and Supplementary Table 2). With this data in
hand, we examined whether all the other proteinogenic
amino acids (1c–1t) behave similarly to Ala 1b. No trace of
product 3b–3t except imine formation 4b–4t was observed with
the amino acids 1b–1t (Fig. 2b and Supplementary Table 2). In a
control experiment, the vortexing of Phe (1n) under the reaction
conditions did not result in its racemization (Fig. 2c and Sup-
plementary Fig. 48). These results reconfirm the presence of a
high barrier to the formation of the NuL in substituted amino
acids (1b–1t, Fig. 2d). We believe that the unfavorable orientation
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Fig. 2 Stable aminoalcohol formation with glycine. a Aldehyde with H-bond acceptors forms a stable aminoalcohol with 1a (also see Supplementary
Fig. 72). b Selective formation of aminoalcohol with 1a. c Stereo-stability of substituted amino acid (1n) under the reaction conditions. d Plausible
mechanism for glycine specific formation of aminoalcohol
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the imine from the Lys side chain (Nɛ-NH2) remains unreactive
for any subsequent transformation (see Supplementary Fig. 73).
N-terminus Gly labeling of large peptides and proteins. To
explore the translation of aminoalcohol chemistry, we selected
melittin 6a [26 residues, one Nα-NH2 (Gly), three Lys Nε-NH2].
The reaction of reagent 2e with 6a led to mono-labeled melittin
7a (52% conversion, Fig. 3a); in a control experiment, RNase A
(N-terminus Lys) resulted in no detectable product in 72 h.
We confirmed the site of labeling (N-terminus Gly) by MS
(labeled G1-Q26, m/z 3027.51 [M+H]+) followed by MS-MS
(Supplementary Fig. 49). Next, we selected a diagnostically
relevant essential hemoprotein myoglobin 6b [153 residues,
one Nα-NH2 (Gly), nineteen Lys Nε-NH2] and vortexed it
with aldehyde 2e. The mono-labeled myoglobin (7b, 40%
conversion) is formed exclusively in this case (Fig. 3a). Peptide
mapping of the enzymatic digest (labeled G1-K16, m/z 1996.37
[M+H]+) and MS-MS confirmed the site of labeling at
N-terminus Gly (Supplementary Fig. 50). It was imperative to
evaluate the chemistry with recombinant proteins. The engi-
neering of Gly at the N-terminus of proteins is convenient36. In
bacteria, the N-terminal Met is excised from proteins exposing
the penultimate Gly with high efficiency37. Also, the recombi-
nant proteins expressed with a recognition sequence for pre-
scission protease renders the desired N-terminus Gly post
proteolytic digestion38. We adopted the latter route and gen-
erated small Ubiquitin-like modifier (SUMO1) protein 6c with
a Gly residue at the N-terminus (see Supplementary informa-
tion for details). The labeling of 6c with 2e went smoothly to
result in N-terminus mono-labeled SUMO1 (7c, 43% conver-




























































Insulin (Gly) 6d, Aprotinin (Arg) 6e, Ubiquitin (Met) 6f, Cytochrome C (Ac-Gly) 6g
Lysozyme C (Lys) 6h, β-Lactoglobulin (Leu) 6i, Chymotrypsinogen A (Cys) 6j
aNaHCO3 buffer (0.1 M, pH 7.8), 50 μM, 48 h, 25 °C
Fig. 3 N-terminus Gly labeling of proteins. a A user-friendly protocol delivers single-site labeling of proteins. Deconvoluted ESI-MS confirms the %
conversion and rules out the possibility of side reactions (also see Supplementary Figs. 70 and 71). R indicates the fragment from reagent 2e attached
to the protein. b Extension of methodology for labeling single protein (insulin 6d) in a mixture of proteins (6d–6j)
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[M+H]+) and MS-MS confirmed the site of labeling at N-
terminus Gly (Supplementary Fig. 51). Next, we selected insulin
6d that contains two N-terminus [51 residues, two Nα-NH2,
chain A (Gly), chain B (Phe), one Lys Nε-NH2]. The imine
formed by Nα-NH2 (Phe) of chain B is established to exhibit the
preferential reactivity21–23. However, the vortexing of insulin
6d with the reagent 2e results in the mono-labeled insulin 7d in
71% conversion (Fig. 3a). The disulfide reduction of 7d, peptide
mapping, and MS-MS led to the identification of Nα-NH2 (Gly)
modification in chain A (labeled G1-N21, m/z 2563.00 [M+H]
+, Supplementary Fig. 52). Next, we selected a mixture of seven
proteins (6d–6j, Fig. 3b). Gratifyingly, the labeling experiment
with reagent 2e resulted in exclusive labeling of N-terminus Gly
bearing insulin 6d to render mono-labeled product 7d (42%
conversion, Fig. 3b and Supplementary Fig. 53). The metho-
dology exhibits remarkable selectivity as none of the other
residues in any protein interfere.
Access to analytically pure tagged proteins. At this stage,
understanding the impact of functional group derivatizations of
2e on the reaction was essential for achieving the downstream
tasks. We found that the amide linkage could be used while
redesigning the reagent 2e to a symmetric bis-aldehyde (2f and
2g, Fig. 4a) with the handle for late-stage modification. Initially,
the reaction of insulin with bis-aldehyde 2f resulted in poor
conversions. However, the incorporation of polyethylene glycol
(PEG)3 linker in redesigned aldehyde 2g regained the solubility of
reagent and efficiency of transformation (88%, step 1, Fig. 4b; for
the reaction of proteins 6a–6c and PfAOS1 6k with 2g, see
Supplementary Figs. 62–64). We did not observe the formation of
insulin–insulin complex (Supplementary Table 3 and Fig. 65).
Initially, we examined the efficiency of late-stage installation with
benzyloxyamine. The product characterization involved disulfide
reduction, peptide mapping, and MS-MS (Supplementary Figs. 54
and 55). Subsequently, we showcased the potential of this
transformation with derivatives of O-hydroxylamine such as 19F
NMR probe 10a, biotin 10b, and a fluorophore 10c (step 2a,
Fig. 4b). The excellent overall conversion (85%, 87%, and 87%,
respectively) over the two steps (steps 1 and 2a; route 1)
while retaining the selectivity is noteworthy (Supplementary
Figs. 56–59). 19F NMR probe attached insulin 11a shows a sharp
NMR signal at −62.80 ppm (Fig. 4 and Supplementary Fig. 66).
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aNaHCO3 buffer (0.1 M, pH 7.8), 20 μM, 24 h, 25 °C. b3–5 h, 25 °C. cOverall % conversion for two steps. dAniline, phosphate buffer (0.1 M, pH
7.0), 10 h. eAniline. phosphate buffer (0.3 M, pH 7.0), 8 h. fOverall % isolated yield for three steps. g% Yield is based on recovered starting





















Fig. 4 Late-stage tagging and isolation of analytically pure tagged proteins. a Design elements of a symmetric bis-aldehyde. b Insulin is labeled through
aminoalcohol formation with reagent 2g. The labeled insulin 9 can be treated with derivatives of O-hydroxylamine 10a–10c for tagging them with 19F-NMR
probe, biotin, and coumarin. Alternatively, it can be immobilized on hydrazide functionalized resin through single-site to deliver 13. The unreacted insulin
6d is recovered and recycled. Subsequent treatment of 13 with 10a delivers analytically pure 11a after removing excess 10a through spin concentration.
The hydrazide functionalized resin 12 is recovered and recycled multiple (5–8) times without loss of activity. Similar protocol renders pure 11b and 11c.
For single-step late-stage installation of a probe, please see Supplementary Fig. 74
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streptavidin (Stv-n) renders a sharp band at ~70 kDa for Stv-11b
complex (Supplementary Fig. 67). The coumarin attached insulin
11c results in fluorescence emission at 428 nm (excitation at 333
nm, Supplementary Fig. 68).
Our next goal was to integrate a purification protocol with the
aminoalcohol chemistry (steps 1, 2b, and 3; route 2; Fig. 4b).
Initially, we mixed the reaction mixture of step 1 (9 + 6d) with
hydrazide functionalized resin (step 2b, Fig. 4b). This step
exhibits excellent efficiency and results in > 95% single-site
immobilization of the labeled protein (9). The unreacted protein
(6d) was recovered with > 95% efficiency and recycled. Finally,
the immobilized protein (13) was released with O-hydroxylamine
derivatives (10a–10c) from resin through transoximization (step
3, Fig. 4b). The centrifugal spin concentration results in the
analytically pure single-site tagged protein (Supplementary
Figs. 60 and 61). The single-site immobilized labeled insulin
rendered efficient parallel installation of 19F NMR probe, biotin,
and fluorophore (three steps, two purifications; 54%, 57%, and
58% overall isolated yields; Supplementary Figs. 60 and 61). The
coumarin tagged insulin (11c) exhibits excellent product stability
over a broad range of pH (3–11) at 25 °C for 36 h (Supplementary
Fig. 76).
Bioactivity assays. Subsequently, we asked how the labeling
would affect the structure and activity of insulin. The earlier
investigations suggest that Nα-NH2 (Gly) of chain A is important
for insulin structure and function39,40. The circular dichroism of
coumarin tagged insulin (11c) confirmed the conservation of
structure (Supplementary Fig. 69). We examined the activity in
cell-based assays using 11c through its ability to activate insulin
receptor (IR) mediated signaling. Activation of insulin-dependent
IR-signaling was assessed by the increase in levels of phospho-Akt
(pSer-473) and subsequent uptake of insulin inside the cells. The
prior is detected by phospho-Akt (pAkt) specific antibodies on
western blotting and immunofluorescence. The latter is assessed
through the coumarin fluorophore signal inside cells. While the
untreated (mock) cells exhibit basal pAkt reactivity, cells treated
with 11c or untagged insulin (6d) render enhanced phospho-Akt
(pAkt) reactivity relative to loading control protein (GAPDH)
(Supplementary Fig. 78a). The quantitation of pAkt signals
relative to loading control GAPDH is represented in Supple-
mentary Fig. 78b. These observations directed us towards the
estimation of EC50 values for native and modified insulin41. Both
native and modified insulin activated the insulin receptor and
pAkt generation with similar efficacy (Fig. 5a). The EC50 values
were estimated to be 2.7 and 2.9 nM for native (6d) and modified
insulin (S29), respectively (Fig. 5b). In the cellular uptake assays,
we observed that cells treated with 11c display coumarin signal
accumulated throughout the cells indicating their regular uptake
(Fig. 5c, 1st row, middle panel). This signal can be competed out
in the presence of excess untagged insulin (11c:6d, 1:3; Fig. 5c, 1st
row, right panel). Concomitant to this, we observe a similar
increase in pAkt signals (pSer-473) in tagged or untagged insulin-
treated cells (Fig. 5d, 1st row middle and right panels). These
observations unambiguously establish that aminoalcohol deriva-
tization of N-Gly in insulin results in no adverse effect on its
capability to activate the insulin receptor signaling. Next, we
investigated the SUMOylation reaction that provides a versatile
tool to identify and characterize novel SUMO enzymes and their
substrates42. We reconstituted the SUMOylation reaction with
modified SUMO1 and monitored the SUMO1-substrate con-
jugate. The data concludes that the N-Gly modification of
SUMO1 does not interfere with its biochemical activity (for
details, see Supplementary Fig. 79).
Residue-specific labeling of a protein in cell lysate. Finally, we
challenged the methodology to precisely label the N-terminus Gly
containing protein in a cell lysate prepared from E. coli BL21
(DE3) cells overexpressing GST-SUMO1. Proteolytic digest gen-
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Fig. 5 Insulin bioactivity assay. a, Bioactivity measurement for native and modified insulin in a dose-dependent pAkt cell-based assay. The error bar
represents standard error of mean (SEM). The assays were repeated at least three times (n= 3). b EC50 value determination from (a), absolute values
obtained by extrapolation of graphs in a are represented by a simple bar graph. c Uptake of tagged insulin (green) and mixture of untagged and tagged
insulin in cells. Chromatin (blue). Also see, Supplementary Fig. 77. d Activation of IR signaling and pAkt (red) accumulation in HEK293T cells after insulin
treatment (scale bar:10 µm). Source data of Fig. 5 panel a provided as Source Data file
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multiple other proteins present in the lysate sample (lanes 1 and
2, Fig. 6). Such a lysate was vortexed with the symmetrical bis-
aldehyde 2g. The late-stage installation of coumarin on the
N-terminal Gly residue is visualized by SDS-PAGE and fluores-
cence imaging. The labeling of SUMO1 is observed without
noticeable participation of any other protein (lane 4, Fig. 6).
Discussion
In summary, we deliver a methodology that enables single-site
residue-specific labeling of a protein. We demonstrated that a
systematic multi-step approach could provide the platform to
solve the multifaceted selectivity challenges. The chemoselective
generation of an electrophilic intermediate followed by site- and
residue-specific formation of a latent nucleophile is the key to
success. The reaction proceeds exclusively with the N-terminus
Gly residue of a protein. The selectivity remains uncompromised
even when the method is extended to a protein in the cell lysate.
The reaction excludes the N-terminus α-amine of other protei-
nogenic amino acids and multiple Lys residues bearing ε-amine.
The absence of competing reactions is one of the most note-
worthy features of this chemical technology. The symmetric bis-
aldehyde reagent allows installation of various tags on single-site
labeled protein. A user-friendly purification protocol enables the
isolation of analytically pure tagged protein. The overall yield of
the product after three steps is remarkable. The protocol offers
convenient imaging of insulin in HEK293T cells without per-
turbing its structure and activity.
Methods
Single-site labeling of a protein. In a 1.5 mL microcentrifuge tube, protein
(3 nmol) was mixed with sodium bicarbonate buffer (120 µl, 0.1 M, pH 7.8). To this
solution, 2-(2-formylphenoxy) acetic acid 2e (1500 nmol) in DMSO (30 µl) from a
freshly prepared stock solution was added and vortexed at 25 °C. The overall
concentration of protein and 2-(2-formylphenoxy)acetic acid was 20 µM and 10
mM respectively. After 24–48 h, the reaction mixture was diluted with acetonitrile:
water (10:90, 3000 µl). Unreacted 2-(2-formylphenoxy)acetic acid and salts were
removed by using Amicon® Ultra-0.5 mL 3-kDa or 10-kDa MWCO centrifugal
spin concentrator. The protein mixture was further washed with Millipore Grade I
water (5 × 0.4 mL). The sample was analyzed by ESI-MS or MALDI-ToF-MS. The
aqueous sample was concentrated by lyophilization before subjecting it to diges-
tion, peptide mapping, and sequencing by MS-MS.
Late-stage tagging and purification of a protein. Hydrazide beads (200 µl,
hydrazide resin loading: 16 µmol mL−1) were taken in a 5 mL fritted polypropylene
chromatography column with end tip closures. Phosphate buffer (0.1 M, pH 7.0,
5 × 1 mL) was used to wash the beads. The beads were re-suspended in phosphate
buffer (100 µl, 0.1 M, pH 7.0). Protein mixture (250 µM) in phosphate buffer (150
µl, 0.1 M, pH 7.0) and aniline (100 mM) in phosphate buffer (100 µl, 0.1 M, pH 7.0)
were added to the beads followed by end-to-end rotation (30 rpm, rotary mixer) at
25 °C. The progress of the immobilization of the labeled protein on hydrazide resin
was monitored by UV-absorbance of the supernatant. After 8–10 h, the super-
natant was collected and the beads were washed with phosphate buffer (0.3 M, pH
7.3, 4 × 1 mL) and KCl (1 M, 3 × 1mL) to remove the adsorbed protein from resin.
The beads were further washed with the phosphate buffer (0.3 M, pH 7.0, 4 × 1 mL)
and re-suspended (phosphate buffer, 200 µl, 0.3 M, pH 7.0). To release the labeled
protein from its immobilized derivative, aniline (100 mM) in phosphate buffer
(100 µl, 0.3 M, pH 7.0) and coumarin or fluoro or biotin derivatives (only one at a
time) of O-hydroxylamine (50 µl, 150 mM in DMSO) were added followed by
vortex at 25 °C for 6–8 h. The supernatant was collected while the salts, aniline, and
O-hydroxylamine were removed using the spin concentrator (3 kDa MWCO). The
purity of the labeled protein was confirmed by ESI-MS. The purification protocol
renders analytically pure tagged protein.
Residue-specific labeling of a protein in cell lysate. The cell lysate was prepared
from E. coli BL21 (DE3) cells overexpressing GST-SUMO1 (section 2d in Supple-
mentary information). Protein concentration was determined by BCA assay and
adjusted to 1.0 mg mL−1. Protein (10 nmol) in sodium bicarbonate buffer (120 µl,
0.1 M, pH 7.8) was taken in a 1.5 mL microcentrifuge tube. To this solution, N,N’-
(((oxybis(ethane-2,1-diyl))bis(oxy))bis(propane-3,1-diyl))bis(2-(2-formylphenoxy)
acetamide) 2g (5000 nmol) in DMSO (30 µl) from a freshly prepared stock
solution was added and vortexed at 25 °C. After 24 h, the reaction mixture was
diluted with acetonitrile:buffer (10:90, 1500 µl). Unreacted N,N’-(((oxybis(ethane-
2,1-diyl))bis(oxy))bis(propane-3,1-diyl))bis(2-(2-formylphenoxy)acetamide) 2g
and salts were removed by spin concentrator (0.5 mL 3-kDa MWCO). The
solution was further washed with sodium bicarbonate buffer (0.1 M, pH 7.8) and
concentrated to 160 µl. To the concentrated sample in sodium bicarbonate buffer,
derivatives of O-hydroxylamine 7-((3-(aminooxy)propyl)thio)-4-methyl-2H-chro-
men-2-one (2 µmol) 10c in DMSO (40 µl) from a freshly prepared stock solution
was added to convert mono-labeled protein to its oxime derivative for 3–6 h.
The excess of O-alkoxyamine and salts were removed by the spin concentrator.
The sample was analyzed by SDS-PAGE.
Biological assays. Imaging assays: The HEK293T (Cell Repository, NCCS, Pune
India) cells were grown in a six-well plate with coverslips in Dulbecco’s modified
Eagle’s medium (DMEM) containing 1% serum for 24 h. Subsequently, the cells
were washed twice with PBS and treated with coumarin tagged 11c and untagged
insulin 6d (3 µg mL−1, 0.5 µM) for 30 min in 10% FBS containing DMEM media.
For competition experiment, tagged and untagged insulin were used in 1:3 ratios in
final 2.0 µM insulin concentration. Post-treatment, cells were again washed twice
with PBS and fixed using 100% chilled methanol for 15 min at −20 °C. The cells
were then rehydrated and permeabilized with rehydration buffer (10 mM Tris, 150
mM NaCl, 0.1% TritonX-100) for 10 min. For coumarin tagged insulin imaging,
nuclei were stained with Hoechst 33342 (Invitrogen) directly after permeabilization
and images were taken. For pAkt imaging, cells were blocked with 5% Normal Goat
Serum (NGS) for 30 min at room temperature after rehydration. The cells were
stained overnight with pAkt antibodies (1:200, Cell Signaling Technology) at 4 °C.
After primary antibody incubation, cells were washed three times with PBS-T
(5 min each). Alexa Fluor-568 conjugated goat anti-rabbit IgG (1:800, Life Tech-
nologies) secondary antibody was used against pAkt. After this, the nuclei were
stained with Hoechst 33342 (Invitrogen), and fluorescence images were captured
on APOTOME/Zeiss LSM 780 confocal microscope. All image analysis was per-
formed using ZEN (Zeiss) or Image J software.
EC50 analysis. For the assay, 50,000 human embryonic kidney cells (HEK293T)
were grown in each well of a 96- well plate to ~50% confluence in DMEM sup-
plemented with 10% fetal bovine serum (FBS) and antibiotics in a humidified
incubator with 5% CO2 at 37 °C. The cells were serum starved for 12 h in no serum
DMEM media and then treated with varying concentrations (100, 10, 5, 2.5, 1, 0.5,
0.1 nM) of insulin and modified insulin in no serum DMEM media for 40 min at
37 °C. After the treatment, the insulin-containing media was removed, cells were
1. 2 g (10 mM)
NaHCO3 buffer
(0.1 M, pH 7.8)
50 μM, 24 h, 25 °C
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Other cellular proteins
a b
Fig. 6 Residue-specific labeling of a protein in the cell lysate. a Selective labeling of N-Gly SUMO1 with coumarin tag in cell lysate. b 12% SDS-PAGE
of cell lysate (overexpressed with SUMO1) and coumarin-tagged SUMO1 7l in cell lysate followed by coomassie staining and fluorescence imaging.
MW—molecular weight, Lanes 1 and 2: cell lysate before and after reaction (Coomassie); lanes 3 and 4: cell lysate before and after reaction (fluorescence).
The band at ~17 kDa (m/z 11.6 kDa) in lanes corresponds to the SUMO1. The band at ~17 kDa (m/z 11.6 kDa) shown by fluorescence imaging in lane 4
confirms the selective tagging of SUMO1 (7l). Source data of Fig. 6 panel b provided as Source Data file
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washed and intracellular level of pAkt Ser473 was measured using HTRF pAkt
Ser473 kit (Cisbio, France, Catalogue No. 64AKSPET and Perkin Elmer, Catalogue
No. TRF4002C) following the manufacturer's protocol. In brief, cells were lysed in
50 µl of supplemented lysis buffer under mild horizontal shaking at room tem-
perature for 45 min. The homogenized cell lysate (16 µl) was added to 4 µl of the
premixed antibody solutions in the HTRF 96-well detection plate. After 4 h of
incubation at room temperature, the absorbance was recorded in a Cytation 5
multi-mode reader (BioTek Instrument, USA).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are available within the Article and its
accompanying Supplementary Information file. The source data underlying Figs. 5a, 6b
and Supplementary Figures 63b, 67, 68, 69, 72, 78a, 79c is provided in the Source Data
file. Raw data for all the NMR spectra and HPLC-MS/ESI-MS/MALDI-ToF-MS can be
accessed from the corresponding author upon reasonable request.
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